Literature DB >> 21826371

Multiple receptor-mediated functions of activated protein C.

H Weiler1.   

Abstract

The central effector protease of the protein C pathway, activated protein C (APC), interacts with the endothelial cell protein C receptor, with protease activated receptors (PAR), the apolipoprotein E2 receptor, and integrins to exert multiple effects on haemostasis and immune cell function. Such receptor interactions modify the activation of PC and determine the biological response to endogenous and therapeutically administered APC. This review summarizes the current knowledge about interactions of APC with cell surface-associated receptors, novel substrates such as histones and tissue factor pathway inhibitor, and their implications for the biologic function of APC in the control of coagulation and inflammation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21826371     DOI: 10.5482/ha-1166

Source DB:  PubMed          Journal:  Hamostaseologie        ISSN: 0720-9355            Impact factor:   1.778


  16 in total

1.  Apolipoprotein E Receptor 2 Mediates Activated Protein C-Induced Endothelial Akt Activation and Endothelial Barrier Stabilization.

Authors:  Ranjeet K Sinha; Xia V Yang; José A Fernández; Xiao Xu; Laurent O Mosnier; John H Griffin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-01-21       Impact factor: 8.311

Review 2.  New insights into modulation of thrombin formation.

Authors:  Henri M H Spronk; Julian I Borissoff; Hugo ten Cate
Journal:  Curr Atheroscler Rep       Date:  2013-11       Impact factor: 5.113

Review 3.  Protease-activated receptor signalling by coagulation proteases in endothelial cells.

Authors:  Alireza R Rezaie
Journal:  Thromb Haemost       Date:  2014-07-03       Impact factor: 5.249

Review 4.  Mechanisms of anticoagulant and cytoprotective actions of the protein C pathway.

Authors:  E A M Bouwens; F Stavenuiter; L O Mosnier
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

Review 5.  Protein C anticoagulant and cytoprotective pathways.

Authors:  John H Griffin; Berislav V Zlokovic; Laurent O Mosnier
Journal:  Int J Hematol       Date:  2012-04-05       Impact factor: 2.490

Review 6.  Cytoprotective-selective activated protein C therapy for ischaemic stroke.

Authors:  Laurent O Mosnier; Berislav V Zlokovic; John H Griffin
Journal:  Thromb Haemost       Date:  2014-09-18       Impact factor: 5.249

7.  Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46.

Authors:  Laurent O Mosnier; Ranjeet K Sinha; Laurent Burnier; Eveline A Bouwens; John H Griffin
Journal:  Blood       Date:  2012-11-13       Impact factor: 22.113

8.  Podocyte Integrin-β 3 and Activated Protein C Coordinately Restrict RhoA Signaling and Ameliorate Diabetic Nephropathy.

Authors:  Thati Madhusudhan; Sanchita Ghosh; Hongjie Wang; Wei Dong; Dheerendra Gupta; Ahmed Elwakiel; Stoyan Stoyanov; Moh'd Mohanad Al-Dabet; Shruthi Krishnan; Ronald Biemann; Sumra Nazir; Silke Zimmermann; Akash Mathew; Ihsan Gadi; Rajiv Rana; Jinyang Zeng-Brouwers; Marcus J Moeller; Liliana Schaefer; Charles T Esmon; Shrey Kohli; Jochen Reiser; Alireza R Rezaie; Wolfram Ruf; Berend Isermann
Journal:  J Am Soc Nephrol       Date:  2020-07-24       Impact factor: 10.121

Review 9.  The emerging role of coagulation proteases in kidney disease.

Authors:  Thati Madhusudhan; Bryce A Kerlin; Berend Isermann
Journal:  Nat Rev Nephrol       Date:  2015-11-23       Impact factor: 28.314

10.  Down-regulation of the clotting cascade by the protein C pathway.

Authors:  Fabian Stavenuiter; Eveline A M Bouwens; Laurent O Mosnier
Journal:  Hematol Educ       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.